| 000 | 01898 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515100250.0 | ||
| 264 | 0 | _c20080502 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1365-2141 | ||
| 024 | 7 |
_a10.1111/j.1365-2141.2007.06913.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEvans, Robert P | |
| 245 | 0 | 0 |
_aThe selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cFeb 2008 |
||
| 300 |
_a295-302 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aAurora Kinase A |
| 650 | 0 | 4 | _aAurora Kinase B |
| 650 | 0 | 4 | _aAurora Kinases |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aOrganophosphates _xtherapeutic use |
| 650 | 0 | 4 |
_aPlasma Cells _xenzymology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xanalysis |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSyndecan-1 _xanalysis |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aNaber, Claudia | |
| 700 | 1 | _aSteffler, Tara | |
| 700 | 1 | _aCheckland, Tamara | |
| 700 | 1 | _aMaxwell, Christopher A | |
| 700 | 1 | _aKeats, Jonathan J | |
| 700 | 1 | _aBelch, Andrew R | |
| 700 | 1 | _aPilarski, Linda M | |
| 700 | 1 | _aLai, Raymond | |
| 700 | 1 | _aReiman, Tony | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 140 _gno. 3 _gp. 295-302 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2007.06913.x _zAvailable from publisher's website |
| 999 |
_c17590053 _d17590053 |
||